Skip to content

A comparative study to show the efficacy of Triphadi ghrita and Albendazole in the management of intestinal worms in children.

A comparative clinical trial to study the effect of Triphaladi ghrita and albendazole in the management of Krimi roga in children. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070861
Enrollment
90
Registered
2024-07-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B80- Enterobiasis

Interventions

None listed

Sponsors

Dr Puja Kumari
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with sign and symptoms of krimi roga. Age 3 to 12 years.

Exclusion criteria

Exclusion criteria: Patients not willing for trial. Patients affected with any systemic disease. Patients on any other medication. Age more than 12 years and less than 3 years.

Design outcomes

Primary

MeasureTime frame
Sign and symptoms will be assessed before and after treatment. Those are teeth grinding, anal itching,pain abdomen,anorexia,patchy apperance on faceTimepoint: at 0day, 15th day and 30th day

Secondary

MeasureTime frame
Stool test before & after treatment for examination of worms, its cyst & ova.Timepoint: Group A- 14 days Group B- 14 days Group C- 14 days

Countries

India

Contacts

Public ContactDr Shilpy Gupta

Government Ayurvedic College, Kadamkuan

arvindschaurasia@gmail.com7631504161

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026